Verrica Pharmaceuticals VRCA
NASDAQ VRCA
$4.74 +0.28 (+6.31%)
As of: Sep 30, 2026 · 1:01 PM EDT

Verrica Pharmaceuticals Inc. (VRCA) Receivables - Other (2022 - 2026)

Updated

Verrica Pharmaceuticals (VRCA) posted Receivables - Other of $2.3 million for Q2 2026.

Analysis

Verrica Pharmaceuticals Inc. (VRCA) Receivables - Other (2022 - 2026) Analysis & Trends

At the end of FY2024, Verrica Pharmaceuticals' Receivables - Other came in at $29,000, down 82.7% from FY2023.

  • In prior years, Verrica Pharmaceuticals' Receivables - Other was $168,000 in FY2023 (+69.7%) and $99,000 in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Receivables - Other in data going back to Q1 2022.
  • The strongest year-over-year quarter for Receivables - Other in the past five years was Q1 2024, with growth of 957.1%; the weakest was Q1 2025, with a decline of 92.2%.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.30 Mn
Mar 31, 2025 46,000.00
Dec 31, 2024 29,000.00
Sep 30, 2024 84,000.00
Jun 30, 2024 182,000.00
Mar 31, 2024 592,000.00
Dec 31, 2023 168,000.00
Sep 30, 2023 126,000.00
Jun 30, 2023 173,000.00
Mar 31, 2023 56,000.00
Dec 31, 2022 99,000.00
Sep 30, 2022 419,000.00
Jun 30, 2022 218,000.00
Mar 31, 2022 431,000.00
API Access

Verrica Pharmaceuticals Inc. Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VRCA&period=max&api_key=YOUR_API_KEY